Ken Griffin Biomerica Inc Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Biomerica Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 53,700 shares of BMRA stock, worth $16,647. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,700Holding current value
$16,647% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding BMRA
# of Institutions
28Shares Held
1.79MCall Options Held
53.7KPut Options Held
0-
Granahan Investment Management, LLC Waltham, MA527KShares$163,5120.01% of portfolio
-
Russell Investments Group, Ltd.225KShares$69,8840.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA169KShares$52,3930.0% of portfolio
-
Potomac Capital Management, Inc.168KShares$51,9870.37% of portfolio
-
Black Rock Inc. New York, NY149KShares$46,2150.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $4.16M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...